Human medicines European public assessment report EPAR Flixabi infliximab...
Human medicines European public assessment report EPAR Flixabi infliximab Spondylitis AnkylosingArthritis RheumatoidCrohn DiseaseColitis UlcerativeArthritis PsoriaticPsoriasis Date of authorisation...
View ArticleArena Pharmaceuticals verkndet strategischen Wachstumsplan fr die nahe und...
San Diego otsPRNewswire Beginn des Phase23Programms zu Etrasimod bei Morbus Crohn CD Zwei zustzliche Phase2Entwicklungsprogramme zu Etrasimod bei eosinophiler sophagitis EoE und...
View ArticleFinch Therapeutics Completes Enrollment in Potentially Pivotal Trial of CP101...
206 patients randomized at 51 centers in a multinational placebocontrolled trial Topline data expected at the end of Q2 2020Finch Therapeutics Group Inc. Finch a clinicalstage microbiome therapeutics...
View ArticleStopping AntiTNF Therapy in Perianal Crohn's Disease
Does stopping antiTNF therapy in patients with perianal Crohn's disease result in relapse Alimentary Pharmacology & Therapeutics
View ArticleToll Like Receptor 4 hToll or CD284 or TLR4 Pipeline Review H1 2019 Report...
Toll Like Receptor 4 hToll or CD284 or TLR4 Pipeline Review H1 2019SummaryAccording to the recently published report 'Toll Like Receptor 4 Pipeline Review H1 2019'; Toll Like Receptor 4 hToll or CD284...
View ArticleConnect Biopharma Reports Positive Topline Data from Moderatetosevere Atopic...
Data show superior efficacy after four weeks of treatment and more rapid onset of action for CBP201 compared with data from studies of current standard of care therapy for AD On Day 29 42.9 and 50.0 of...
View ArticleTiziana Reports Phase 1 Clinical Data Demonstrating Oral Treatment with...
This announcement contains inside information for the purposes of Article 7 of EU Regulation 5962014.Tiziana Life Sciences plc NasdaqTLSA Tiziana or the Company a biotechnology company focused on...
View ArticleHuman medicines European public assessment report EPAR Inflectra infliximab...
Human medicines European public assessment report EPAR Inflectra infliximab Arthritis PsoriaticSpondylitis AnkylosingColitis UlcerativePsoriasisCrohn DiseaseArthritis Rheumatoid Date of authorisation...
View ArticleLerner and Rowe Honor the Memory of Dana MarshallBernstein by Supporting the...
LAS VEGAS PRWEB January 11 2020 Lerner and Rowe Injury Attorneys is honored to pay tribute to the memory of Dana MarshallBernstein by supporting the Crohn&39;s and Colitis FoundationÂÂ...
View ArticleArcutis Announces Exercise of Option for Exclusive License to Highly...
ARQ252 potential to offer "Best in Class" topical JAK therapyPhase 2b study in adult patients with hand eczema anticipated to start in the first half of 2020WESTLAKE VILLAGE CA...
View ArticleArena Pharmaceuticals Inc ARNA Financial and Strategic SWOT Analysis Review...
Arena Pharmaceuticals Inc ARNA Financial and Strategic SWOT Analysis Review provides you an indepth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by...
View ArticleFungal Alterations in Inflammatory Bowel Diseases
This review explores the role of gut fungi in patients with Crohn's disease and ulcerative colitis. Might modulation of the fungal microbiota present a therapeutic opportunity for IBD Alimentary...
View ArticlePatient Groups Including Global Healthy Living Foundation File Brief to Argue...
In partnership with more than a dozen patient organizations the Global Healthy Living Foundation today announced the filing of an amicus brief with the United States Court of Appeals for the District...
View ArticleRho Associated Protein Kinase 1 Pipeline Review H2 2019 Published by Global...
Rho Associated Protein Kinase 1 Pipeline Review H2 2019SummaryAccording to the recently published report 'Rho Associated Protein Kinase 1 Pipeline Review H2 2019'; Rho Associated Protein Kinase 1 Renal...
View ArticleAbivax Receives Clearance from U.S. FDA to Initiate Clinical Trials with...
DGAPNews ABIVAX Key words Study20.01.2020 1837 The issuer is solely responsible for the content of this announcement.Abivax Receives Clearance from U.S. FDA to Initiate Clinical Trials with ABX464 to...
View ArticleNon Receptor Tyrosine Protein Kinase TYK2 Pipeline Review H2 2019 Published...
Non Receptor Tyrosine Protein Kinase TYK2 Pipeline Review H2 2019SummaryNon Receptor Tyrosine Protein Kinase TYK2 TYK2 or EC 2.7.10.2 pipeline Target constitutes close to 24 molecules. Out of which...
View ArticlePredictImmune Announces Commercial Partnership With Cambridge Clinical...
Partnership with CCL signals PredictImmunes ever increasing focus on driving sales of PredictSure IBD across existing and new marketsPredictImmune developers of pioneering prognostic tools for guiding...
View ArticleIBD Diagnoses Rising in Children
Advances in antiTNF drugs will be in the spotlight at the upcoming Crohn's and Colitis Congress. One expert believes a cure will come in the lifetime of some of the children he currently treats....
View ArticleTiziana Life Sciences Announces Appointment of Mr. Gregor MacRae to...
Tiziana Life Sciences plc "Tiziana" or the "Company" Nasdaq TLSA AIM TILS a biotechnology company focusing on the discovery and development of innovative therapeutics for inflammation and oncology...
View ArticleVedolizumab and Malignancy Incidence
This study analyzed the longterm incidence of malignancy with vedolizumab a gutselective antibody approved to treat moderatetosevere Crohn's disease and ulcerative colitis in adults. Alimentary...
View Article